JP2009254242A - Novel sweetener having sugar-like taste, method for producing the same, and use of the sweetener - Google Patents
Novel sweetener having sugar-like taste, method for producing the same, and use of the sweetener Download PDFInfo
- Publication number
- JP2009254242A JP2009254242A JP2008104326A JP2008104326A JP2009254242A JP 2009254242 A JP2009254242 A JP 2009254242A JP 2008104326 A JP2008104326 A JP 2008104326A JP 2008104326 A JP2008104326 A JP 2008104326A JP 2009254242 A JP2009254242 A JP 2009254242A
- Authority
- JP
- Japan
- Prior art keywords
- sweetener
- sugar
- tagatose
- glucose
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000003599 food sweetener Nutrition 0.000 title claims abstract description 59
- 239000003765 sweetening agent Substances 0.000 title claims abstract description 59
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- 235000000346 sugar Nutrition 0.000 claims abstract description 62
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 claims abstract description 44
- 235000013305 food Nutrition 0.000 claims abstract description 44
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 43
- 239000008103 glucose Substances 0.000 claims abstract description 17
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 41
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 30
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 22
- 235000013361 beverage Nutrition 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 18
- 239000002537 cosmetic Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 10
- 229930091371 Fructose Natural products 0.000 claims description 8
- 239000005715 Fructose Substances 0.000 claims description 8
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 5
- 210000000214 mouth Anatomy 0.000 claims description 2
- 239000007788 liquid Substances 0.000 abstract description 20
- 208000008589 Obesity Diseases 0.000 abstract description 12
- 235000020824 obesity Nutrition 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 230000003405 preventing effect Effects 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 13
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 8
- 235000019688 fish Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 235000015067 sauces Nutrition 0.000 description 6
- 108700040099 Xylose isomerases Proteins 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000014171 carbonated beverage Nutrition 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 244000144972 livestock Species 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 235000012970 cakes Nutrition 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000021438 curry Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 210000001596 intra-abdominal fat Anatomy 0.000 description 4
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 108010011485 Aspartame Proteins 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000013580 sausages Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000001145 Metabolic Syndrome Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 241000269851 Sarda sarda Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- -1 medical products Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000014594 pastries Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 235000019685 rice crackers Nutrition 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000013547 stew Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000020152 coffee milk drink Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000021549 curry roux Nutrition 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012020 french fries Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 235000014109 instant soup Nutrition 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000007510 mood change Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000012461 sponges Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000011870 unpaired t-test Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000012773 waffles Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Abstract
Description
本発明は、果糖ブドウ糖液糖(異性化糖)の構成成分であるDグルコースおよびDフラクトースとD-タガトースの混合物を含む甘味料、その使用用途、特に食品素材、医療品、化粧品に応用する技術に関する。 The present invention relates to a sweetener containing D glucose and a mixture of D-fructose and D-tagatose, which are constituents of fructose-glucose liquid sugar (isomerized sugar), a use application thereof, particularly a technique applied to food materials, medical products, and cosmetics. About.
澱粉を糖化して糖化液とし、これをグルコースイソメラーゼで処理して製造される異性化糖は、生産コストの安さから、ソフトドリンクや他の飲料に甘味料として広く使用され、アメリカでは800万トン以上消費されている。代表的な方法では澱粉を酵素で加水分解してデキストリンとし、これを更に別の酵素で加水分解してブドウ糖溶液、すなわち糖化液とする。この糖化液中にはブドウ糖の他にオリゴ糖が若干含まれている。グルコースイソメラーゼによるブドウ糖の果糖への異性化反応は平衡反応であり、異性化糖のD-グルコースとD-フラクトースとの比率は通常58:42程度である。さらに、甘味不足を解消するために、精製D-フラクトースを添加する場合があるが、この場合最終のD-グルコースとD-フラクトースとの比率は通常45:55程度である。上記の通り、異性化糖は、経済的メリットにより広く使われているが、日本、アメリカなどをはじめとする先進国において、高血糖や過体重(肥満)(「メタボリックシンドローム」)などの原因として疑われている(非特許文献1)。 Isomerized sugar produced by saccharifying starch into a saccharified solution and treating it with glucose isomerase is widely used as a sweetener in soft drinks and other beverages due to its low production cost. More than consumed. In a typical method, starch is hydrolyzed with an enzyme to form dextrin, and this is further hydrolyzed with another enzyme to obtain a glucose solution, that is, a saccharified solution. This saccharified solution contains some oligosaccharides in addition to glucose. The isomerization reaction of glucose to fructose by glucose isomerase is an equilibrium reaction, and the ratio of D-glucose and D-fructose of the isomerized sugar is usually about 58:42. Furthermore, purified D-fructose may be added in order to eliminate the lack of sweetness. In this case, the final ratio of D-glucose to D-fructose is usually about 45:55. As mentioned above, isomerized sugars are widely used due to their economic merits, but in advanced countries such as Japan and the United States, they are the cause of hyperglycemia and overweight (obesity) ("metabolic syndrome"). It is suspected (Non-Patent Document 1).
また、異性化糖の甘味度や甘味質は、広く一般に使用されている砂糖に比べ、差が見られ、DグルコースとD-フラクトースの比を変えることになどにより、砂糖の甘味度、甘味質に近づける工夫がされているが、満足のいくものは未だ得られていない。 In addition, the sweetness and sweetness of isomerized sugars are different from those of widely used sugar, and the sweetness and sweetness of sugar can be improved by changing the ratio of D-glucose and D-fructose. Although it has been devised to make it closer to, no satisfactory one has been obtained yet.
一方、D-タガトースは、希少糖の一種であるが、D-ガラクトースをアルカリ処理することにより生産され、血糖値の上昇を防ぐことなどが知られている。
特許文献1および2には、D-タガトースと非栄養性甘味料及びエリスリトールを含めることにより甘味を持たせることによるダイエット飲料や食品の味質を改善することが記載されている。また、非栄養性甘味料としてアスパルテーム、アセスルファムK等の高甘味度甘味料が開示されている。
しかし、非栄養性甘味料であるアスパルテーム、アセスルファムK等とD-タガトースだけでは、時として味覚が軽すぎる(ボディ感が不足する)ことになる欠点があった。
On the other hand, D-tagatose is a kind of rare sugar, and is known to be produced by treating D-galactose with an alkali to prevent an increase in blood sugar level.
Patent Documents 1 and 2 describe that D-tagatose, non-nutritive sweetener and erythritol are included to improve the taste quality of diet drinks and foods by imparting sweetness. In addition, high-intensity sweeteners such as aspartame and acesulfame K are disclosed as non-nutritive sweeteners.
However, aspartame, acesulfame K, etc., which are non-nutritive sweeteners, and D-tagatose alone have a drawback that the taste is sometimes too light (the body feeling is insufficient).
本発明は、広く食品業界で甘味料として使われている果糖ブドウ糖液糖の第一の問題点、すなわち、甘味度、甘味質ともに砂糖とは異なっていることを改善して、従来の果糖ブドウ糖液糖を砂糖の甘味度および味質に非常に近い甘味料として提供することを目的とする。
また、本発明は、広く食品業界で甘味料として使われている果糖ブドウ糖液糖の第二の問題点、すなわち、肥満などの生活習慣病の原因となることを改善して、味質を改善することで得たD-タガトースを含む甘味料として提供することを目的とする。
さらにまた、本発明は、D-タガトースを含む甘味料を用いた医薬品もしくは医薬部外品、化粧品を提供することを目的とする。
The present invention improves the first problem of fructose-glucose liquid sugar widely used as a sweetener in the food industry, that is, the difference in sweetness and sweetness from sugar. The purpose is to provide liquid sugar as a sweetener that is very close to the sweetness and taste of sugar.
In addition, the present invention improves the taste by improving the second problem of fructose-glucose liquid sugar, which is widely used as a sweetener in the food industry, that is, causing lifestyle-related diseases such as obesity It aims at providing as a sweetener containing D-tagatose obtained by doing.
Furthermore, an object of the present invention is to provide a pharmaceutical, a quasi-drug, or a cosmetic using a sweetener containing D-tagatose.
本発明者は、上記課題を解決すべく、鋭意研究を重ねてきた。その中で、ある一定のD-グルコース、D-フラクトース、D-タガトース比からなる、新規甘味料が、甘味度、甘味質が砂糖に近く、その上肥満等の生活習慣病の予防効果を持つことを発見し、本発明を完成するに至った。 The present inventor has intensively studied to solve the above problems. Among them, a new sweetener consisting of a certain ratio of D-glucose, D-fructose, and D-tagatose has a sweetness and sweetness similar to sugar and has a preventive effect on lifestyle-related diseases such as obesity. This has been discovered and the present invention has been completed.
すなわち、本発明は、以下の(1)ないし(3)に記載の甘味料を要旨としている。
(1)フラクトース、グルコースおよびタガトースを必須成分とする砂糖の甘味度および味質を有する甘味料。
(2)D-フラクトース30〜80重量部に対して、D-グルコースおよびD-タガトースの合計が70〜20重量部である(1)に記載の甘味料。
(3)D-グルコースおよびD-タガトースの合計を100重量部とした場合、D-タガトースが10重量部以上含まれる(2)に記載の甘味料。
That is, the gist of the present invention is the sweetener described in the following (1) to (3).
(1) A sweetener having the sweetness and taste of sugar containing fructose, glucose and tagatose as essential components.
(2) The sweetener according to (1), wherein the total amount of D-glucose and D-tagatose is 70 to 20 parts by weight with respect to 30 to 80 parts by weight of D-fructose.
(3) The sweetener according to (2), wherein 10 parts by weight or more of D-tagatose is contained when the total amount of D-glucose and D-tagatose is 100 parts by weight.
また、本発明は、以下の(4)および(5)に記載の飲食物を要旨としている。
(4)(1)ないし(3)のいずれかに記載の甘味料を使用してなる飲食物。
(5)炭水化物100重量部に対して、5重量部以上のD-タガトースを含む、(4)に記載の飲食品。
Moreover, this invention makes the summary the food and drink as described in the following (4) and (5).
(4) A food or drink comprising the sweetener according to any one of (1) to (3).
(5) The food or beverage according to (4), comprising 5 parts by weight or more of D-tagatose with respect to 100 parts by weight of carbohydrates.
さらにまた、本発明は、以下の(6)および(7)に記載の医薬品もしくは医薬部外品、口腔用組成物、化粧品を要旨としている。
(6)(1)ないし(3)のいずれかに記載の甘味料を使用してなる医薬品もしくは医薬部外品、口腔用組成物、化粧品。
(7)炭水化物100重量部に対して、5重量部以上のD-タガトースを含む、(6)に記載の医薬品もしくは医薬部外品、口腔用組成物、化粧品。
Furthermore, the gist of the present invention is the pharmaceuticals or quasi drugs, oral compositions, and cosmetics described in (6) and (7) below.
(6) A pharmaceutical or quasi-drug, composition for oral cavity, and cosmetics using the sweetener according to any one of (1) to (3).
(7) The pharmaceutical or quasi-drug, oral composition, cosmetics according to (6), which contains 5 parts by weight or more of D-tagatose with respect to 100 parts by weight of carbohydrates.
本発明により、広く食品業界で甘味料として使われている果糖ブドウ糖液糖の第一の問題点、すなわち、甘味度、甘味質ともに砂糖とは異なっていることの改善として、従来の果糖ブドウ糖液糖にD-タガトースを併用することにより、砂糖の甘味度および味質に非常に近い甘味料を提供することができる。
また、本発明により、広く食品業界で甘味料として使われている果糖ブドウ糖液糖の第二の問題点、すなわち、肥満などの生活習慣病の原因となることの改善として、D-タガトースを含む甘味料を提供することができる。
さらにまた、本発明は、D-タガトースを含む甘味料を用いた医薬品もしくは医薬部外品、化粧品を提供することができる。
According to the present invention, as a first problem of fructose-glucose liquid sugar widely used as a sweetener in the food industry, that is, to improve the difference in sweetness and sweetness from sugar, conventional fructose-glucose liquid By using D-tagatose in combination with sugar, a sweetener very close to the sweetness and taste of sugar can be provided.
Further, according to the present invention, D-tagatose is included as an improvement in the second problem of fructose-glucose liquid sugar widely used as a sweetener in the food industry, that is, the cause of lifestyle-related diseases such as obesity. Sweeteners can be provided.
Furthermore, the present invention can provide a pharmaceutical, a quasi-drug, or a cosmetic using a sweetener containing D-tagatose.
本発明の甘味料の具体的態様は、D-フラクトースの割合が20〜80重量部、好ましくは30〜80重量部、D-グルコースとD-タガトースの合計の割合が80〜20重量部、好ましくは70〜20重量部で、かつ、D-フラクトース、D-グルコースおよびD-タガトースの合計を100重量部とした場合、D-タガトースが2重量部以上、好ましくは10重量部以上含まれる、砂糖の甘味度と味質に近く肥満などの生活習慣病を予防する新規甘味料である。 In a specific embodiment of the sweetener of the present invention, the proportion of D-fructose is 20 to 80 parts by weight, preferably 30 to 80 parts by weight, and the total proportion of D-glucose and D-tagatose is preferably 80 to 20 parts by weight. Is 70 to 20 parts by weight, and when the total of D-fructose, D-glucose and D-tagatose is 100 parts by weight, sugar containing 2 parts by weight or more, preferably 10 parts by weight or more of D-tagatose It is a novel sweetener that is close to the sweetness and quality of potato and prevents lifestyle-related diseases such as obesity.
本発明の新規甘味料の概略を説明すると、その成分であるD-フラクトース、D-グルコース、D-タガトースの混合物であり、各成分を混合して得られる。D-フラクトース、D-グルコースは、天然界で一般に存在する単糖であり、天然界から単離して得られるほか、D-フラクトースは、D-グルコースをグルコースイソメラーゼ処理して得られた果糖ブドウ糖液糖等から分離して得られる。また、D-グルコースは、澱粉を加水分解して製造されている。また、D-タガトースは、天然界では、わずかしか存在しない希少糖の一種で、D-ガラクトースをアルカリ処理することに等により得られる。 The outline of the novel sweetener of the present invention will be described. It is a mixture of its components D-fructose, D-glucose and D-tagatose, and is obtained by mixing each component. D-fructose and D-glucose are monosaccharides that are generally present in nature, and are obtained by isolation from the natural world. D-fructose is a fructose glucose solution obtained by treating D-glucose with glucose isomerase. It is obtained by separating from sugar and the like. D-glucose is produced by hydrolyzing starch. In addition, D-tagatose is a kind of rare saccharide that does not exist in the natural world, and is obtained by treating D-galactose with an alkali.
本発明の新規甘味料において、D-フラクトースと(D-グルコースとD-タガトースの合計)の比は80〜20重量部:20〜80重量部が好ましい。D-フラクトースは、80部以上になると甘みが増す反面ボディー感が低下する。またD-フラクトースが20部以下では、甘み感に物足りなさを感じる傾向にある。また、D-タガトースがD-グルコースおよびD-タガトースの合計を100重量部とした場合、2重量部以上、好ましくは10重量部の比率で砂糖の甘味度および味質を有する甘味料となり、また、全体の3重量部以上の比率で内臓脂肪蓄積予防効果が顕著になり、好ましくは5重量部以上の比率で内臓脂肪蓄積予防効果がより顕著になる。 In the novel sweetener of the present invention, the ratio of D-fructose and (total of D-glucose and D-tagatose) is preferably 80 to 20 parts by weight: 20 to 80 parts by weight. When D-fructose exceeds 80 parts, the sweetness increases, but the body feeling decreases. When the D-fructose is 20 parts or less, the sweetness tends to be unsatisfactory. When D-tagatose is 100 parts by weight of the total of D-glucose and D-tagatose, it becomes a sweetener having a sweetness and taste of sugar at a ratio of 2 parts by weight or more, preferably 10 parts by weight, The visceral fat accumulation preventing effect becomes remarkable at a ratio of 3 parts by weight or more as a whole, and the visceral fat accumulation preventing effect becomes more remarkable at a ratio of preferably 5 parts by weight or more.
本発明の甘味料の製造方法の詳細を説明する。
本発明の甘味料を、製造するのに際し、果糖ブドウ糖液糖、D-グルコース、または澱粉を出発原料とし、本発明の甘味料を製造することが可能である。
例えば、(1)果糖ブドウ糖液糖を、澱粉または、D-グルコースからつくり、さらに、これにD-タガトースを添加混合してつくる。
(1)分解果糖ブドウ糖液糖液の作成
分解果糖ブドウ糖液糖は、定法に従いとうもろこし、馬鈴薯あるいは甘藷などのデンプンを原料に、固定化したもしくはバッチによるアルファアミラーゼ、グルコアミラーゼ、グルコースイソメラーゼなどの酵素を用い製造する。澱粉原料および用いる酵素の種類は上記に限定されるものではない。また、必要によっては酸分解によるブドウ糖液製造、アルカリを用いた異性化を行っても良い。
The detail of the manufacturing method of the sweetener of this invention is demonstrated.
In producing the sweetener of the present invention, it is possible to produce the sweetener of the present invention using fructose-glucose liquid sugar, D-glucose, or starch as a starting material.
For example, (1) fructose dextrose liquid sugar is made from starch or D-glucose, and further D-tagatose is added and mixed.
(1) Preparation of degraded fructose-glucose liquid sugar liquid Degraded fructose-glucose liquid sugar is prepared from starch, such as corn, potato, or sweet potato, according to a standard method, and an enzyme such as alpha amylase, glucoamylase, glucose isomerase, etc., immobilized or batch-processed. Use to manufacture. The types of starch raw materials and enzymes used are not limited to the above. If necessary, glucose solution production by acid decomposition and isomerization using alkali may be performed.
このようにして得られた新規甘味料は、好みによりアスパルテームやステビアなどの甘味料と併用することもできる。またボディ感の付与などのため、甘味度が低い水溶性食物繊維(ポリデキストロースや難消化性デキストリンなど)を適宜加えても良い。 The novel sweetener thus obtained can be used in combination with sweeteners such as aspartame and stevia depending on the taste. In addition, water-soluble dietary fiber (polydextrose, indigestible dextrin, etc.) having a low sweetness may be added as appropriate to impart a body feeling.
本発明の甘味料において、D-フラクトースの割合が20〜80重量部、好ましくは30〜80重量部、(D-グルコースおよびD-タガトースの合計)の割合が、80〜20重量部、好ましくは70〜20重量部程度であるが、甘味度および甘味質を生かして用いる場合は、その含量は、特に制限されない。目的とする機能の度合い、使用態様、使用量等により適宜調整することができる。 In the sweetener of the present invention, the proportion of D-fructose is 20 to 80 parts by weight, preferably 30 to 80 parts by weight, and the proportion of (total of D-glucose and D-tagatose) is 80 to 20 parts by weight, preferably Although it is about 70 to 20 parts by weight, the content is not particularly limited when the sweetness and sweetness are utilized. It can be appropriately adjusted depending on the degree of the intended function, the usage mode, the usage amount, and the like.
本発明の新規甘味料は、D−タガトースを含有するもので、肥満予防効果を有する。
D−タガトースの含有率は、全体の3重量部以上で、ラットによる肥満予防効果が顕著であり、好ましくは5重量部以上でラットによる肥満予防効果がより顕著である。
また、生活習慣病予防ということで、他の有効成分と併用混合して用いることもできる。
The novel sweetener of the present invention contains D-tagatose and has an obesity preventing effect.
When the content of D-tagatose is 3 parts by weight or more of the whole, the obesity-preventing effect by the rat is remarkable, and preferably 5 parts by weight or more, the obesity-preventing effect by the rat is more remarkable.
Moreover, it can also be used in combination with other active ingredients because of lifestyle-related disease prevention.
本発明の甘味料は、食品、保健用食品、患者用食品、食品素材、保健用食品素材、患者
用食品素材、食品添加物、保健用食品添加物、患者用食品添加物、飲料、保健用飲料、患者用飲料、飲料水、保健用飲料水、患者用飲料水、薬剤、製剤原料、飼料、患畜および/または患獣用飼料になど甘味を必要とするものすべてに使用することができる。
The sweetener of the present invention is food, health food, patient food, food material, health food material, patient food material, food additive, health food additive, patient food additive, beverage, health care It can be used for beverages, patient beverages, drinking water, health drinking water, patient drinking water, medicines, pharmaceutical raw materials, feeds, livestock and / or livestock feeds that require sweetness.
本発明の甘味料を食品に利用する場合、そのままの形態、水溶液、オイルなどに懸濁した形態、乳液状形態食、または食品業界で一般的に使用される担体を添加した形態などのものを調製してもよい。飲料の形態は、非アルコール飲料またはアルコール飲料である。非アルコール飲料としては、例えば、炭酸系飲料、果汁飲料、ネクター飲料などの非炭酸系飲料、清涼飲料、スポーツ飲料、茶、コーヒー、ココアなど、また、アルコール飲料の形態では薬用酒などの一般食品の形態を挙げることができる。
本発明の甘味料(組成物)の、前記糖質代謝異常および/または脂質代謝異常改善を目的とした食品素材あるいは食品添加物としての使用形態としては、錠剤、カプセル剤、飲料などに溶解させる粉末あるいは顆粒などの固形剤、ゼリーなどの半固形体、飲料水などの液体、希釈して用いる高濃度溶液などがある。
さらに、本発明の甘味料(組成物)を適宜食品に添加して糖質代謝異常および/または脂質代謝異常改善などを目的とした保健食または病人食とすることができる。任意的成分として、通常食品に添加されるビタミン類、炭水化物、色素、香料など適宜配合することができる。食品は液状または固形の任意の形態で食することができる。ゼラチンなどで外包してカプセル化した軟カプセル剤として食することができる。カプセルは、例えば、原料ゼラチンに水を加えて溶解し、これに可塑剤(グリセリン、D− ソルビトールなど)を加えることにより調製したゼラチン皮膜でつくられる。
When the sweetener of the present invention is used in foods, it can be used as it is, in an aqueous solution, suspended in oil, etc., in a milk form, or in a form to which a carrier generally used in the food industry is added. It may be prepared. The form of the beverage is a non-alcoholic beverage or an alcoholic beverage. Non-alcoholic beverages include, for example, non-carbonated beverages such as carbonated beverages, fruit juice beverages, and nectar beverages, soft drinks, sports beverages, tea, coffee, cocoa, and other general foods such as medicinal liquors in the form of alcoholic beverages. Can be mentioned.
The use form of the sweetener (composition) of the present invention as a food material or food additive for the purpose of improving abnormal sugar metabolism and / or abnormal lipid metabolism is dissolved in tablets, capsules, beverages and the like. Examples thereof include solid agents such as powder or granules, semi-solid bodies such as jelly, liquids such as drinking water, and high-concentration solutions used after dilution.
Furthermore, the sweetener (composition) of the present invention can be appropriately added to foods to provide a health food or sick food for the purpose of improving abnormal sugar metabolism and / or abnormal lipid metabolism. As optional components, vitamins, carbohydrates, pigments, fragrances and the like that are usually added to foods can be appropriately blended. The food can be eaten in any form, liquid or solid. It can be eaten as a soft capsule encapsulated by gelatin or the like. The capsule is made of, for example, a gelatin film prepared by adding water to raw gelatin and dissolving it, and adding a plasticizer (glycerin, D-sorbitol, etc.) thereto.
本発明の甘味料は砂糖と同様な用途で用いることができる。また、調理やお茶、コーヒーなどにも使用できる。 The sweetener of this invention can be used for the same use as sugar. It can also be used for cooking, tea and coffee.
飲食物としては、具体的には以下のものを例示することができる。洋菓子類( プリン、ゼリー、グミキャンディー、キャンディー、ドロップ、キャラメル、チューインガム、チョコレート、ペストリー、バタークリーム、カスタードグリーム、シュークリーム、ホットケーキ、パン、ポテトチップス、フライドポテト、ポップコーン、ビスケット、クラッカー、パイ、スポンジケーキ、カステラ、ワッフル、ケーキ、ドーナツ、ビスケット、クッキー、せんべい、おかき、おこし、まんじゅう、あめなど)、乾燥麺製品( マカロニ、パスタ)、卵製品( マヨネーズ、生クリーム)、飲料( 機能性飲料、乳酸飲料、乳菌飲料、濃厚乳性飲料、果汁飲料、無果汁飲料、果肉飲料、透明炭酸飲料、果汁入り炭酸飲料、果実着色炭酸飲料)、嗜好品(緑茶、紅茶、インスタントコーヒー、ココア、缶入りコーヒードリンク) 、乳製品( アイスクリーム、ヨーグルト、コーヒー用ミルク、バター、バターソース、チーズ、発酵乳、加工乳)、ペースト類( マーマレード、ジャムフラワーペースト、ピーナッツペースト、フルーツペースト、果実のシロップ漬け)、畜肉製品( ハム、ソーセージ、ベーコン、ドライソーセージ、ビーフジャーキー、ラード)、魚介類製品( 魚肉ハム、魚肉ソーセージ、蒲鉾、ちくわ、ハンペン、魚の干物、鰹節、鯖節、煮干し、うに、いかの塩辛、スルメ、魚のみりん干し、貝の干物、鮭などの燻製品)、佃煮類( 小魚、貝類、山菜、茸、昆布)、シチュウー、カレー類( 即席カレー、レトルトカレー、缶詰カレー) 、調味料剤(みそ、粉末みそ、醤油、粉末醤油、もろみ、魚醤、ソース、ケチャップ、オイスターソース、固形ブイヨン、焼き肉のたれ、カレールー、シチューの素、スープの素、だしの素、ペースト、インスタントスープ、ふりかけ、ドレッシング、サラダ油)、揚げ製品( 油揚げ、油揚げ菓子、即席ラーメン)、豆乳、マーガリン、ショートニングなどを挙げることができる。 Specific examples of food and drink include the following. Pastry (pudding, jelly, gummy candy, candy, drop, caramel, chewing gum, chocolate, pastry, butter cream, custard cream, cream puff, hot cake, bread, potato chips, french fries, popcorn, biscuits, crackers, pie, sponge Cakes, castella, waffles, cakes, donuts, biscuits, cookies, rice crackers, rice crackers, rice cakes, manju, candy, etc., dried noodle products (macaroni, pasta), egg products (mayonnaise, fresh cream), beverages (functional beverages, Lactic acid beverages, lactobacillus beverages, concentrated milk beverages, fruit juice beverages, fruitless beverages, pulp beverages, transparent carbonated beverages, carbonated beverages with fruit juice, fruit colored carbonated beverages), luxury products (green tea, tea, instant coffee, cocoa, cans Coffee Link), dairy products (ice cream, yogurt, coffee milk, butter, butter sauce, cheese, fermented milk, processed milk), pastes (marmalade, jam flour paste, peanut paste, fruit paste, fruit syrup pickles), Livestock products (ham, sausage, bacon, dry sausage, beef jerky, lard), seafood products (fish meat ham, fish sausage, salmon, chikuwa, hampen, dried fish, bonito, bonito, boiled and dried, sea urchin, salted squid , Plums, dried fish, shellfish, salmon products), boiled fish (small fish, shellfish, wild vegetables, sea bream, kelp), stew, curry (instant curry, retort curry, canned curry), seasoning Agent (Miso, powdered miso, soy sauce, powdered soy sauce, moromi, fish sauce, sauce, ketchup, oyster saw , Solid bouillon, grilled meat sauce, curry roux, stew sauce, soup sauce, soup stock, paste, instant soup, sprinkle, dressing, salad oil), fried products (fried food, fried confectionery, instant ramen), soy milk, margarine, Shortening etc. can be mentioned.
上記飲食物は、本発明の甘味料(組成物)を常法に従って、一般食品の原料と配合することにより、加工製造することができる。上記飲食物への組成物の配合量は食品の形態により異なり特に限定されるものではないが、通常は0 . 1〜 5 0重量% が好ましい。 The said food and drink can be processed and manufactured by mix | blending the sweetener (composition) of this invention with the raw material of a general food according to a conventional method. The amount of the composition to be added to the food and drink varies depending on the form of the food and is not particularly limited, but is usually preferably 0.1 to 50% by weight.
上記飲食物は、機能性食品、栄養補助食品或いは健康食品類としても用いることができる。その形態は、特に限定されるものではなく、例えば、食品の製造例としては、アミノ酸バランスのとれた栄養価の高い乳蛋白質、大豆蛋白質、卵アルブミンなどの蛋白質、これらの分解物、卵白のオリゴペプチド、大豆加水分解物などの他、アミノ酸単体の混合物などを、常法に従って使用することができる。また、ソフトカプセル、タブレットなどの形態で利用することもできる。 The above food and drink can also be used as functional foods, nutritional supplements or health foods. The form is not particularly limited, and examples of food production include milk proteins with high amino acid balance, soy protein, and proteins such as egg albumin, degradation products thereof, and egg white oligos. In addition to peptides, soybean hydrolysates, and the like, mixtures of amino acids alone can be used according to conventional methods. It can also be used in the form of a soft capsule, a tablet or the like.
栄養補助食品或いは機能性食品の例としては、糖類、脂肪、微量元素、ビタミン類、乳化剤、香料などが配合された流動食、半消化態栄養食、成分栄養食、ドリンク剤、カプセル剤、経腸栄養剤などの加工形態を挙げることができる。上記各種食品には、例えば、スポーツドリンク、栄養ドリンクなどの飲食物は、栄養バランス、風味を良くするために、更にアミノ酸、ビタミン類、ミネラル類などの栄養的添加物や甘味料、香辛料、香料、色素などを配合することもできる。 Examples of dietary supplements or functional foods include liquid foods, semi-digested nutritional foods, ingredient nutritional foods, drinks, capsules, and sucrose containing sugars, fats, trace elements, vitamins, emulsifiers, and fragrances. Processing forms such as enteral nutrients can be mentioned. In the above-mentioned various foods, for example, foods and drinks such as sports drinks and nutritional drinks are further supplemented with nutritional additives such as amino acids, vitamins and minerals, sweeteners, spices and fragrances to improve nutritional balance and flavor. , Pigments and the like can also be blended.
本発明の甘味料(組成物)は、家畜、家禽、ペット類の飼料用に応用することができる。例えば、ドライドッグフード、ドライキャットフード、ウェットドッグフード、ウェットキャットフード、セミモイストドックフード、養鶏用飼料、牛、豚などの家畜用飼料に配合することができる。飼料自体は、常法に従って調製することができる。
また、本発明の甘味料(組成物)を応用した治療剤および予防剤は、ヒト以外の動物、例えば、牛、馬、豚、羊などの家畜用哺乳類、鶏、ウズラ、ダチョウなどの家禽類、は虫類、鳥類或いは小型哺乳類などのペット類、養殖魚類などにも用いることができる。
The sweetener (composition) of the present invention can be applied to feed for livestock, poultry and pets. For example, it can mix | blend with livestock feeds, such as dry dog food, dry cat food, wet dog food, wet cat food, semi-moist dock food, poultry feed, cattle, and pigs. The feed itself can be prepared according to a conventional method.
In addition, therapeutic agents and preventive agents to which the sweetener (composition) of the present invention is applied include non-human animals, for example, domestic mammals such as cows, horses, pigs, and sheep, and poultry such as chickens, quails, and ostriches. , Can be used for reptiles, birds, pets such as small mammals, farmed fish and the like.
本発明の甘味料の、甘味を生かしつつ、生理作用の発現を意図した糖質代謝異常および/または脂質代謝異常改善効果、肥満改善効果を目的とした薬剤は、これらを単独で用いるほか、一般的賦形剤、安定剤、保存剤、結合剤、崩壊剤などの適当な添加剤を配合し、液剤、顆粒剤、細粒剤、散剤、錠剤、カプセル剤、丸剤、軟膏剤、貼付剤、散布剤、スプレー剤または注射剤等の適当な剤型を選んで製剤し、経口的、経鼻的、経皮的あるいは経静脈的に投与することができる。 The sweetener of the present invention is a drug intended to improve the abnormalities of carbohydrate metabolism and / or lipid metabolism abnormalities and obesity to improve the physiological effects while taking advantage of sweetness. Suitable excipients, stabilizers, preservatives, binders, disintegrants, etc. are added, and liquids, granules, fine granules, powders, tablets, capsules, pills, ointments, patches An appropriate dosage form such as a spray, spray or injection can be selected and formulated, and can be administered orally, nasally, transdermally or intravenously.
経口投与、経鼻投与、経皮投与または経静脈投与に適した医薬用の有機又は無機の固体、半固体又は液体の担体、溶解剤もしくは希釈剤を、本発明の組成物を薬剤として調製するために用いることができる。水、ゼラチン、乳糖、デンプン、ステアリン酸マグネシウム、タルク、動・植物油、ベンジルアルコール、ガム、ポリアルキレングリコール、石油樹脂、ヤシ油、ラノリン、又は医薬に用いられる他のキャリアー(担体)は全て、本発明の組成物を含む薬剤の担体として用いることができる。また、安定剤、湿潤剤、乳化剤や、浸透圧を変えたり、配合剤の適切なp Hを維持するための塩類を補助薬剤として適宜用いることができる。 A pharmaceutical organic or inorganic solid, semi-solid or liquid carrier, solubilizer or diluent suitable for oral, nasal, transdermal or intravenous administration is prepared using the composition of the present invention as a medicament. Can be used for All water, gelatin, lactose, starch, magnesium stearate, talc, animal and vegetable oils, benzyl alcohol, gum, polyalkylene glycol, petroleum resin, coconut oil, lanolin, or other carriers used in medicine are all It can be used as a carrier for a medicament containing the composition of the invention. In addition, stabilizers, wetting agents, emulsifiers, and salts for changing the osmotic pressure or maintaining an appropriate pH of the compounding agent can be appropriately used as auxiliary agents.
また、化粧品等の製剤化に、可溶性フィルムが使用されるようになってきている。例えば、香料等を保持させたフレーバーフィルム等として気分転換、口臭予防等を目的として、可食性の可溶性フィルムが使用されている。また、保湿剤等を保持させた化粧品用フィルムを、パックとして使用したり、水に溶解して乳液として使用するといったアイディアも出されている。更に、抗炎症剤等を保持させて湿布薬として使用したりすることも検討されている。食品、医薬品等の包装材として、又食品、医薬品等の有効成分を保持する担体として、優れた溶解性とフィルム特性を示し、これらの用途に好適に用いることができる可溶性フィルムが提案されており(特開2007-091696号公報)、このようにして、本発明の砂糖の甘味度および味質を有する甘味料を医薬品もしくは医薬部外品、化粧品に適応することができる。 In addition, soluble films have been used for the formulation of cosmetics and the like. For example, an edible soluble film is used as a flavor film retaining a fragrance or the like for the purpose of mood change, prevention of bad breath, and the like. In addition, the idea of using a cosmetic film holding a moisturizer or the like as a pack, or dissolving it in water and using it as an emulsion has been presented. Furthermore, it has been studied to use an anti-inflammatory agent or the like as a poultice. As a packaging material for foods and pharmaceuticals, and as a carrier for holding active ingredients such as foods and pharmaceuticals, a soluble film that exhibits excellent solubility and film properties and can be suitably used for these applications has been proposed. Thus, the sweetener having the sweetness and taste of sugar of the present invention can be applied to pharmaceuticals, quasi-drugs, and cosmetics as described above (Japanese Patent Laid-Open No. 2007-091696).
本発明を実施例によりさらに詳細に説明するが、本発明は実施例によってなんら限定されるものではない。 The present invention will be described in more detail with reference to examples. However, the present invention is not limited to the examples.
〈D−フラクトースおよび、D-グルコースおよび、D−タガトースを含有する糖液の調製〉
デンプンに、水およびαアミラーゼを加え、95℃前後で分解した。液化終了後55℃まで冷却し、グルコアミラーゼを加えさらに小さく分解しブドウ糖液を生成させた。このブドウ糖液糖をグルコースイソメラーゼを固定化したカラムに60℃にて流し込み、異性化糖を生成させた。
これに所定量の市販D−タガトースを表1に記載の割合で添加混合溶解し、本発明の甘味料(D〜H、J〜L)および比較例(A〜C、I、M)を製造した。
<Preparation of sugar solution containing D-fructose, D-glucose and D-tagatose>
Water and α-amylase were added to the starch and decomposed at around 95 ° C. After completion of liquefaction, the mixture was cooled to 55 ° C., glucoamylase was added, and the mixture was further broken down to produce a glucose solution. This glucose liquid sugar was poured into a column on which glucose isomerase had been immobilized at 60 ° C. to produce isomerized sugar.
A predetermined amount of commercially available D-tagatose was added, mixed and dissolved in the ratio shown in Table 1, and the sweeteners (D to H, J to L) and comparative examples (A to C, I and M) of the present invention were produced. did.
[試験例1]
〈D−フラクトースおよびD-グルコースおよびD−タガトースを含有する糖液の官能検査〉
パネラー9名を用い、上記で製造した本発明の甘味料、及び比較例の10%(w/v)糖液を調整し、味質試験を行った。
評価は、砂糖10%(w/v)糖液と同じ甘味度を示す糖液および、砂糖と比べ「軽い」、「変わらない」、「重い」の3種類から甘味質を選択させた。選択した人数を求め、官能試験結果を表1に示した。パネラーの構成は、20歳代〜30歳代の味覚に精通した男女9名であった。
[Test Example 1]
<Sensory test of sugar solution containing D-fructose, D-glucose and D-tagatose>
Using nine panelists, the sweetener of the present invention produced above and the 10% (w / v) sugar solution of Comparative Example were prepared, and a taste test was conducted.
In the evaluation, a sweet taste was selected from a sugar solution showing the same sweetness as a sugar 10% (w / v) sugar solution and “light”, “not changed”, and “heavy” compared to sugar. The number of selected persons was determined, and the sensory test results are shown in Table 1. The panel consisted of 9 men and women who were familiar with the taste of the 20s and 30s.
異性化糖における甘味度および甘味質は、D-フラクトースとD-グルコースの含有比率により異なる。異性化糖(フラクトース55重量部:グルコース45重量部;I)用いて官能検査を行うと、砂糖に比較し軽い甘さを感じるというコメントが多く認められた。上記結果においても、甘味度3名および甘味質3名のみで、砂糖の味質、甘味度から離れていることが考えられる。一方、官能試験結果から、砂糖の甘味度および/または味質に近い組み合わせは、フラクトース30重量部から80重量部の範囲においてD-グルコースおよびD-タガトースを(70重量部から20重量部)の範囲で含む混合糖であることが明らかとなった。さらに、Hの結果から、グルコース:タガトースの比が、9:1程度で砂糖に近い甘味度および甘味質が得られた。このことから、全量を100重量としたグルコースとの比において、タガトースが約10重量部以上で好ましい甘味度および甘味質が得られることが明らかとなった。一般的に単一成分の甘味料に比較して、混合糖は甘味のピーク幅が広がり丸い甘味特性を示すことが知られている。
また、図1の甘味曲線に示されるように、D-タガトースが加わることによって、甘味曲線は異性化糖(フラクトース+グルコース)の曲線から混合糖曲線(フラクトース+グルコース+タガトース)のように変化し、砂糖の味質に近づいたことがわかる。
これらのことから、D-フラクトースは、きれの良い清涼感のある味質を呈するのに対し、D-タガトースは、砂糖に比較的近い特性があると考えられる。
The sweetness and sweetness of isomerized sugars vary depending on the content ratio of D-fructose and D-glucose. When a sensory test was performed using isomerized sugar (fructose 55 parts by weight: glucose 45 parts by weight; I), many comments were felt that the sweetness was felt compared to sugar. In the above results, it can be considered that only 3 people with sweetness and 3 people with sweetness are separated from the taste and sweetness of sugar. On the other hand, from the results of the sensory test, the combination close to the sweetness and / or taste of sugar has a content of D-glucose and D-tagatose (70 to 20 parts by weight) in the range of 30 to 80 parts by weight of fructose. It became clear that it was a mixed sugar included in the range. Furthermore, from the result of H, a sweetness and sweetness close to sugar were obtained at a glucose: tagatose ratio of about 9: 1. From this, it was clarified that preferable sweetness and sweetness can be obtained when tagatose is about 10 parts by weight or more in the ratio of glucose to 100% by weight. In general, it is known that mixed sugars exhibit a round sweetness characteristic with a broad peak of sweetness compared to a single-component sweetener.
As shown in the sweetness curve of FIG. 1, the addition of D-tagatose changes the sweetness curve from an isomerized sugar (fructose + glucose) curve to a mixed sugar curve (fructose + glucose + tagatose). You can see that the taste of sugar is approaching.
From these facts, D-fructose exhibits a clean and refreshing taste, whereas D-tagatose is considered to have properties relatively close to sugar.
〈D−フラクトースおよび、D-グルコース、D−タガトースを含有する酸性飲料の製造〉
表2に示す割合にて本発明の新規甘味料およびショ糖を用いた飲料を作成した。
<Production of acidic beverage containing D-fructose, D-glucose and D-tagatose>
Beverages using the novel sweetener and sucrose of the present invention were prepared at the ratios shown in Table 2.
その結果、得られた飲料は、ほぼ砂糖同様の好ましい甘味度および甘味質を示した。 As a result, the obtained beverage showed a preferable sweetness and sweetness similar to sugar.
[試験例]
D-タガトースの内臓脂肪蓄積、血清脂質、および血糖値に対する影響に関してラットを用いて調べた。
(実験方法)
実験動物としては、3週齢の雄性Sprague-Dawley ラットを用いた。群としては、D-タガトース群(D-タガトース3重量%)および、D-タガトースをα‐コーンスターチに置き換えたコントロール群とした。実験飼料(表3)と水を自由摂取とし4週間飼育した。飼育終了後、解剖を行った。解剖時に採血および、内臓および体脂肪を採取しその重量を測定した。測定値は平均値および標準誤差で表わし、有意差検定は対応のないt検定を用いて行った。
The effects of D-tagatose on visceral fat accumulation, serum lipids, and blood glucose levels were examined using rats.
(experimental method)
As experimental animals, 3-week-old male Sprague-Dawley rats were used. The groups were a D-tagatose group (D-tagatose 3% by weight) and a control group in which D-tagatose was replaced with α-corn starch. Experimental feed (Table 3) and water were fed freely and were bred for 4 weeks. After breeding, dissection was performed. Blood was collected at the time of dissection, and internal organs and body fat were collected and weighed. The measured values were expressed as mean values and standard errors, and the significance test was performed using an unpaired t-test.
(結果)
体重および餌の摂取量に関しては、有意な低下は認められなかった(実験中の観察からは、動物の行動にも顕著な変化は認められなかった。)(表4)。脂肪重量に関しては、コントロール群の体脂肪重量と比較して、D-タガトース群が有意な低下が認められた(表5)。このことから、D-タガトースの少量の摂取は、有害な体重減少など副作用を認めることなしに、体脂肪、特に内臓脂肪の減少作用を示すことが明らかとなった。血清脂質および血糖に関しては、タガトース群(D-タガトース3重量%)は、コントロール群と比較し、HDL-C(HDL-コレステロール)値の増加、トリグリセリドの低下および、血糖値の低下傾向が認められた(表6)。
(result)
There was no significant decrease in body weight or food intake (observed during the experiment, no significant changes were observed in animal behavior) (Table 4). Regarding fat weight, a significant decrease was observed in the D-tagatose group compared to the body fat weight in the control group (Table 5). From this, it was clarified that a small amount of D-tagatose ingested a body fat, particularly visceral fat, without any side effects such as harmful weight loss. Regarding serum lipids and blood glucose, the tagatose group (D-tagatose 3% by weight) has higher HDL-C (HDL-cholesterol) levels, lower triglycerides, and lower blood glucose levels than the control group. (Table 6).
本発明により、食品業界等で広く使われても、肥満やメタボリックシンドローム、生活習慣病の原因とならない新規甘味料を提供することができる。 The present invention can provide a novel sweetener that does not cause obesity, metabolic syndrome, or lifestyle-related diseases even when widely used in the food industry and the like.
Claims (7)
The pharmaceutical or quasi-drug, oral composition and cosmetic according to claim 6, comprising 5 parts by weight or more of D-tagatose per 100 parts by weight of carbohydrates.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008104326A JP4915959B2 (en) | 2008-04-14 | 2008-04-14 | Novel sweetener with sugar-like taste, production method and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008104326A JP4915959B2 (en) | 2008-04-14 | 2008-04-14 | Novel sweetener with sugar-like taste, production method and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009254242A true JP2009254242A (en) | 2009-11-05 |
JP4915959B2 JP4915959B2 (en) | 2012-04-11 |
Family
ID=41382507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008104326A Active JP4915959B2 (en) | 2008-04-14 | 2008-04-14 | Novel sweetener with sugar-like taste, production method and use thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4915959B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9060962B2 (en) | 2008-11-04 | 2015-06-23 | University Of Kentucky Research Foundation | D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof |
EP2772141A4 (en) * | 2012-12-26 | 2015-07-01 | Japan Corn Starch Co Ltd | Liquid sweetener composition |
JP2016135148A (en) * | 2016-04-28 | 2016-07-28 | キユーピー株式会社 | Acidic oil-in-water type emulsified liquid seasoning |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004520073A (en) * | 2001-04-27 | 2004-07-08 | ペプシコ,インコーポレイテッド | Use of erythritol and D-tagatose in diets or reduced calorie beverages and foods |
JP2004520072A (en) * | 2001-05-01 | 2004-07-08 | ペプシコ,インコーポレイテッド | Use of erythritol and D-tagatose in zero or low calorie beverages and foods |
WO2008036276A2 (en) * | 2006-09-18 | 2008-03-27 | Mcneil Nutritionals, Llc | Balancing heat of solution in non-free flowing sweetener compositions |
-
2008
- 2008-04-14 JP JP2008104326A patent/JP4915959B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004520073A (en) * | 2001-04-27 | 2004-07-08 | ペプシコ,インコーポレイテッド | Use of erythritol and D-tagatose in diets or reduced calorie beverages and foods |
JP2004520072A (en) * | 2001-05-01 | 2004-07-08 | ペプシコ,インコーポレイテッド | Use of erythritol and D-tagatose in zero or low calorie beverages and foods |
WO2008036276A2 (en) * | 2006-09-18 | 2008-03-27 | Mcneil Nutritionals, Llc | Balancing heat of solution in non-free flowing sweetener compositions |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9060962B2 (en) | 2008-11-04 | 2015-06-23 | University Of Kentucky Research Foundation | D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof |
EP2772141A4 (en) * | 2012-12-26 | 2015-07-01 | Japan Corn Starch Co Ltd | Liquid sweetener composition |
CN104936463A (en) * | 2012-12-26 | 2015-09-23 | 日本玉米淀粉株式会社 | Liquid sweetener composition |
CN111602799A (en) * | 2012-12-26 | 2020-09-01 | 日本玉米淀粉株式会社 | Liquid sweetener composition |
JP2016135148A (en) * | 2016-04-28 | 2016-07-28 | キユーピー株式会社 | Acidic oil-in-water type emulsified liquid seasoning |
Also Published As
Publication number | Publication date |
---|---|
JP4915959B2 (en) | 2012-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5639759B2 (en) | Novel sweetener with sugar-like taste, production method and use thereof | |
JP5535456B2 (en) | A biological function-improving composition comprising dietary fiber and a rare sugar. | |
JP5876205B2 (en) | Method for improving deficiency of sweetness of D-sorbose in sweetener comprising D-sorbose and improving sweetness persistence | |
JP6013712B2 (en) | Biometabolic parameter improving agent comprising D-psicose as an active ingredient | |
JP5112865B2 (en) | Composition for preventing or treating hemoglobinuria or myoglobinuria | |
KR102303570B1 (en) | Agent or method for treatment and/or prevention of accelerated energy expenditure and/or diminished energy expenditure functionality | |
JP5240810B2 (en) | Use of D-psicose to suppress an increase in blood D-fructose concentration | |
JP5749880B2 (en) | Body fat accumulation improving agent and metabolic syndrome improving agent comprising D-tagatose as an active ingredient | |
TW200410702A (en) | Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material | |
JP4915959B2 (en) | Novel sweetener with sugar-like taste, production method and use thereof | |
TW202106310A (en) | Composition for promoting GLP-1 secretion | |
KR101697260B1 (en) | Composition Comprising Voglibose As a Prebiotic for Improving Intestinal Microflora or Preventing Obesity | |
JP5943516B2 (en) | Sweetener for improving biological function comprising D-sorbose as an active ingredient | |
JP7216260B2 (en) | Composition for promoting growth of Coprococcus spp. | |
JP2023175314A (en) | Composition for bowel movement improvement and functional display food product | |
JP2023175313A (en) | Functional composition and functional display food product | |
WO2023243210A1 (en) | Myoblast proliferation promoting agent, composition for promoting myoblast proliferation, muscular atrophy inhibiting agent, and composition for inhibiting muscular atrophy | |
TW202408479A (en) | Parasympathetic nerve activator and parasympathetic nerve activating composition | |
JP2022121730A (en) | Anti-fatigue agent | |
JP2023055389A (en) | Proliferation promoting agents for bacteria belonging to the genus bacteroides | |
WO2019022216A1 (en) | Amino acid composition for muscle strength improvement | |
TW201825011A (en) | Composition for improving protein efficiency ratio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110210 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110829 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110902 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111021 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111109 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111115 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120118 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120120 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150203 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4915959 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |